Catalyst Funds Management Pty LTD Kymera Therapeutics, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 800 shares of KYMR stock, worth $38,904. This represents 0.01% of its overall portfolio holdings.
Number of Shares
800Holding current value
$38,904% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
64.4MCall Options Held
45.1KPut Options Held
32.6K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$323 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$292 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$251 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$238 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$231 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.66B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...